Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

Related Articles by Review for PubMed (Select 17132624)

1.

Crystal structure of the tyrosine kinase domain of colony-stimulating factor-1 receptor (cFMS) in complex with two inhibitors.

Schubert C, Schalk-Hihi C, Struble GT, Ma HC, Petrounia IP, Brandt B, Deckman IC, Patch RJ, Player MR, Spurlino JC, Springer BA.

J Biol Chem. 2007 Feb 9;282(6):4094-101. Epub 2006 Nov 28.

2.

Growth factor receptors: structure, mechanism, and drug discovery.

McInnes C, Sykes BD.

Biopolymers. 1997;43(5):339-66. Review.

PMID:
9566117
3.

Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies.

Matsumura I, Mizuki M, Kanakura Y.

Cancer Sci. 2008 Mar;99(3):479-85. doi: 10.1111/j.1349-7006.2007.00717.x. Epub 2008 Jan 2. Review.

PMID:
18177485
4.

Novel protein kinases and molecular mechanisms of autoinhibition.

Cheetham GM.

Curr Opin Struct Biol. 2004 Dec;14(6):700-5. Review.

PMID:
15582394
5.

Design strategies for protein kinase inhibitors.

Parang K, Sun G.

Curr Opin Drug Discov Devel. 2004 Sep;7(5):617-29. Review.

PMID:
15503864
6.

Class III receptor tyrosine kinases: role in leukaemogenesis.

Reilly JT.

Br J Haematol. 2002 Mar;116(4):744-57. Review. No abstract available.

PMID:
11886377
7.

Protein kinase inhibitors: insights into drug design from structure.

Noble ME, Endicott JA, Johnson LN.

Science. 2004 Mar 19;303(5665):1800-5. Review.

PMID:
15031492
8.
9.

Flavonoids as RTK inhibitors and potential anticancer agents.

Teillet F, Boumendjel A, Boutonnat J, Ronot X.

Med Res Rev. 2008 Sep;28(5):715-45. Review.

PMID:
18080331
10.

Natural product derived receptor tyrosine kinase inhibitors: identification of IGF1R, Tie-2, and VEGFR-3 inhibitors.

Stahl P, Kissau L, Mazitschek R, Giannis A, Waldmann H.

Angew Chem Int Ed Engl. 2002 Apr 2;41(7):1174-8. Review. No abstract available.

PMID:
12491250
11.

The sema domain.

Gherardi E, Love CA, Esnouf RM, Jones EY.

Curr Opin Struct Biol. 2004 Dec;14(6):669-78. Review.

PMID:
15582390
12.

Oncogenic potential of the c-FMS proto-oncogene (CSF-1 receptor).

Roussel MF, Sherr CJ.

Cell Cycle. 2003 Jan-Feb;2(1):5-6. Review. No abstract available.

13.

Kinomics: characterizing the therapeutically validated kinase space.

Vieth M, Sutherland JJ, Robertson DH, Campbell RM.

Drug Discov Today. 2005 Jun 15;10(12):839-46. Review.

PMID:
15970266
14.

Signal transduction by the colony-stimulating factor-1 receptor; comparison to other receptor tyrosine kinases.

Lee AW.

Curr Top Cell Regul. 1992;32:73-181. Review. No abstract available.

PMID:
1318184
15.

Molecular regulation of receptor tyrosine kinases in hematopoietic malignancies.

Correll PH, Paulson RF, Wei X.

Gene. 2006 Jun 7;374:26-38. Epub 2006 Mar 9. Review.

PMID:
16524673
16.

Putting two and two together: crystal structure of the FGF-receptor complex.

Wiesmann C, de Vos AM.

Structure. 1999 Nov 15;7(11):R251-5. Review.

PMID:
10574803
17.

Receptor tyrosine kinases: from biology to pathology.

Choura M, Rebaï A.

J Recept Signal Transduct Res. 2011 Dec;31(6):387-94. doi: 10.3109/10799893.2011.625425. Epub 2011 Oct 31. Review.

PMID:
22040163
18.

KIDs rule: regulatory phosphorylation of RTKs.

Locascio LE, Donoghue DJ.

Trends Biochem Sci. 2013 Feb;38(2):75-84. doi: 10.1016/j.tibs.2012.12.001. Epub 2013 Jan 9. Review.

PMID:
23312584
19.

Small molecule discoidin domain receptor kinase inhibitors and potential medical applications.

Li Y, Lu X, Ren X, Ding K.

J Med Chem. 2015 Apr 23;58(8):3287-301. doi: 10.1021/jm5012319. Epub 2015 Jan 21. Review.

PMID:
25569119
20.

Juxtamembrane autoinhibition in receptor tyrosine kinases.

Hubbard SR.

Nat Rev Mol Cell Biol. 2004 Jun;5(6):464-71. Review. No abstract available.

PMID:
15173825
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk